ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban

ENTRUST AF-PCI completes the trials of NOACs in patients with AF who undergo PCI, showing dual therapy with edoxaban was noninferior to vitamin K-antagonist – based triple therapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news